Skip to content

Pharminent

cropped-banner_frontpage_2026-07-11-2.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • M&A / Deals
  • Merck KGaA acquires JSR chromatography business
  • M&A / Deals

Merck KGaA acquires JSR chromatography business

Pharmaceutical Business Review

This follows the company's signing of a definitive agreement in October 2025 to acquire the business.

M&A / DealsRead full story

pharminent April 2, 2026 (Last updated: April 2, 2026)

Pharmaceutical Business Review

This follows the company’s signing of a definitive agreement in October 2025 to acquire the business.

M&A / DealsRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Biocytogen and Sihuan partner to advance new therapeutics for weight loss
Next: Building What’s Next: Join Industry Leaders to Shape Access and Affordability Trends Ahead of Asembia AXS26

Related Stories

  • M&A / Deals

Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar

pharminent July 10, 2026
  • M&A / Deals

GSK ends dementia alliance with Alector after setbacks

pharminent July 9, 2026
  • M&A / Deals

AstraZeneca, GSK intensify China ties with Sino Biopharm deals

pharminent July 8, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.